343
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Mutational analysis of GALT gene in Greek patients with galactosaemia: identification of two novel mutations and clinical evaluation

, , , , , , & show all
Pages 423-427 | Received 04 Feb 2017, Accepted 21 May 2017, Published online: 23 Jun 2017

References

  • Holton JB, Walter JH, Tyfield LA. Galactosemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The metabolic and molecular basis of inherited disease. 8th edn. New York: McGraw-Hill; 2001: 1553–83.
  • Welling L, Boelen A, Derks TG, Schielen PC, de Vries M, Williams M, Wijburg FA, Bosch AM. Nine years of newborn screening for classical galactosemia in the Netherlands: effectiveness of screening methods, and identification of patients with previously unreported phenotypes. Mol Genet Metab 2017;120:223–8.
  • Welling L, Bernstein LE, Berry GT, Burlina AB, Eyskens F, Gautschi M, Grünewald S, Gubbels CS, Knerr I, Labrune P, van der Lee JH, MacDonald A, Murphy E, Portnoi PA, Õunap K, Potter NL, Rubio-Gozalbo ME, Spencer JB, Timmers I, Treacy EP, Van Calcar SC, Waisbren SE, Bosch AM. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis 2017;40:171–6.
  • Tsakiris S, Schulpis KH, Marinou K, Behrakis P. Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+, K+, -ATPase and Mg2+ -ATPase activities induced by the in vitro galactosaemia. Pharmacol Res 2004;49:475–9.
  • Marinou K, Tsakiris S, Tsopanakis C, Schulpis KH, Behrakis P. Mg2+-ATPase activity in suckling rat brain regions in galactosaemia in vitro. L-Cysteine and glutathione effects. Toxicol in Vitro 2005;19:167–72.
  • Tsakiris S, Michelakakis H, Schulpis KH. Erythrocyte membrane acetylcholinesterase, Na+, K+-ATPase and Mg2+-ATPase activities in patients with classical galactosaemia. Acta Paediatr 2005;94:1223–6.
  • Marinou K, Tsakiris S, Tsopanakis C, Schulpis KH, Behrakis P. Suckling rat brain regional distribution of acetylcholinesterase activity in galactosaemia in vitro. Metab Brain Dis 2005;20:227–36.
  • Schulpis KH, Papassotiriou I, Tsakiris S. 8-hydroxy-2-desoxyguanosine serum concentrations as a marker of DNA damage in patients with classical galactosaemia. Acta Paediatr 2006;95:164–9.
  • Schulpis KH, Karikas GA, Papakonstantinou ED, Kalogerakou M, Tsakiris S. The effect of diet on paraoxonase 1/arylesterase activities in patients with disorders of galactose metabolism. Clin Endocrinol (Oxf) 2007;67:687–92.
  • Shield JP, Wadsworth EJ, MacDonald A, Stephenson A, Tyfield L, Holton JB, Marlow N. The relationship of genotype to cognitive outcome in galactosaemia. Arch Dis Child 2000;83:248–50.
  • Kaufman FR, McBride-Chang C, Manis FR, Wolff JA, Nelson MD. Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur J Pediatr 1995;154:S2–S5.
  • Antshel KM, Epstein IO, Waisbren SE. Cognitive strengths and weaknesses in children and adolescents homozygous for galactosemia Q188R mutation: a descriptive study. Neuropsycology 2004;18:658–64.
  • Schadewaldt P, Hoffmann B, Hammen HW, Kamp G, Schweitzer-Krantz S, Wendel U. Longitudinal assessment of intellectual achievement in patients with classical galactosemia. Pediatrics 2010;125:e374–81.
  • Potter NL, Lazarus JA, Johnson JM, Steiner RD, Shriberg LD. Correlates of language impairment in children with galactosaemia. J Inherit Metab Dis 2008;31:524–32.
  • Potter NL, Nievergelt Y, Shriberg LD. Motor and speech disorders in classic galactosemia. JIMD Rep 2013;11:31–41.
  • Hoffmann B, Wendel U, Schweitzer-Krantz S. Cross-sectional analysis of speech and cognitive performance in 32 patients with classic galactosemia. J Inherit Metab Dis 2011;34:421–7.
  • Schulpis K, Kalogerakou M, Monopolis I. Incidence of galactose metabolic disorders in Greece. Minerva Pediatr 2016;68:505–7.
  • Viggiano E, Marabotti A, Burlina AP, Cazzorla C, D’apice MR, Giordano L, Fasan I, Novelli G, Facchiano A, Burlina AB. Clinical and molecular spectrum in galactosemic patients from neonatal screening in northeastern Italy: structural and functional characterization of new variations in the galactose-1-phosphate uridyltransferase (GALT) gene. Gene 2015;559:112–8.
  • Seyrantepe V, Ozguc M, Coskun T, Ozalp I, Reichardt JK. Identification of mutations in the galactose-1-phosphate uridyltransferase (GALT) gene in 16 Turkish patients with galactosemia, including a novel mutation of F294Y. Mutation in brief no. 235. Online. Hum Mutat 1999;13:339.
  • Schulpis K, Papakonstantinou ED, Michelakakis H, Podskarbi T, Patsouras A, Shin Y. Screening for galactosemia in Greece. Pediatr Perinatal Epidimiol 1997;11:436–40.
  • Dunn LM, Dunn LM. Peabody picture vocabulary test. Circle Pines (MN): American Guidance Service; 1981.
  • Deggouj N, Estienne F, Derue L, Vanderlinden F, Ovaert C, Sluysmans T, Gersdorff M. Evaluation of the efficiency of ERTL4/6 screening tests for language disorders for children with a 22q11 deletion. Rev Laryngol Otol Rhinol (Bord) 2009;130:41–4.
  • Woolger C. Wechsler Intelligence Scale for Children – 3rd ed (WISC-III). In: Dorfman WI, Hersen M, eds. Understanding psychological assessment. Boston (MA): Springer US; 2001: 219–33.
  • Segal S, Berry GT. Disorders of galactose metabolism In the metabolic and molecular basis of inherited disease. In: Scriver CR, Beaudet AL, Sly WS, et al. eds. 7th edn. New York: McGraw-Hill 1995;1:967–1000.
  • Calderon FR, Phansalkar AR, Crockett DK, Miller M, Mao R. Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene. Hum Mutat 2007;28:939–43.
  • Tyfield L, Reichardt J, Fridovich-Keil J, Croke DT, Elsas LJ, Strobl W, Kozak L, Coskun T, Novelli G, Okano Y, Zekanowski C, Shin Y, Boleda MD. Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat 1999;13:417–30.
  • Fridovich-Keil JL, Gubbels CS, Spencer JB, Sanders RD, Land JA, Rubio-Gozalbo E. Ovarian function in girls and women with GALT-deficiency galactosemia. J Inherit Metab Dis 2011;34:357–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.